Boxer Capital’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,189,943
| Closed | -$16.6M | – | 12 |
|
2024
Q3 | $16.6M | Hold |
1,189,943
| – | – | 0.81% | 36 |
|
2024
Q2 | $16.4M | Hold |
1,189,943
| – | – | 0.86% | 30 |
|
2024
Q1 | $19.7M | Hold |
1,189,943
| – | – | 0.97% | 30 |
|
2023
Q4 | $17.4M | Hold |
1,189,943
| – | – | 0.87% | 29 |
|
2023
Q3 | $14.6M | Hold |
1,189,943
| – | – | 0.78% | 39 |
|
2023
Q2 | $14.2M | Hold |
1,189,943
| – | – | 0.66% | 41 |
|
2023
Q1 | $15.9M | Hold |
1,189,943
| – | – | 0.78% | 37 |
|
2022
Q4 | $25.6M | Hold |
1,189,943
| – | – | 1.35% | 28 |
|
2022
Q3 | $23.8M | Hold |
1,189,943
| – | – | 1.34% | 26 |
|
2022
Q2 | $21.3M | Hold |
1,189,943
| – | – | 1.35% | 27 |
|
2022
Q1 | $11.8M | Hold |
1,189,943
| – | – | 0.61% | 39 |
|
2021
Q4 | $20.1M | Hold |
1,189,943
| – | – | 0.78% | 30 |
|
2021
Q3 | $28.2M | Hold |
1,189,943
| – | – | 0.99% | 28 |
|
2021
Q2 | $27.1M | Buy |
+1,189,943
| New | +$27.1M | 0.96% | 29 |
|